Studies including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have demonstrated reduced cardiovascular events in patients with type 2 diabetes
Wu T, Bound MJ, Zhao BR, Standfield SD, Bellon M, Jones KL, et al
Disclaimer: These statements have not been evaluated by the Food and Drug Administration (FDA)
No chronic toxicity has been documented in animal research (Vukojevic et al., 2020)
Lawsuits alleging vision loss, such as NAION, are also being organized in consolidated proceedings but remain individual claims rather than a class action
Autophagy Autophagy, a vital homeostatic process, generally functions as a protective mechanism for cell survival [125, 126]